Outcome of secondary Acute Myeloid Leukemia treated with Hypomethylating agent plus Venetoclax ( HMA‐Ven ) or Liposomal Daunorubicin‐Cytarabine ( CPX ‐351)
Journal article published in 2021 by
Amandeep Salhotra 
,
Ahmed Aribi,
Dat Ngo,
Jianying Zhang,
Karamjeet Sandhu,
Monzr Al‐Malki,
Haris Ali,
Paul Koller ,
Shukaib Arslan ,
Elizabeth Budde,
Samer Khaled,
Sanjeet Dadwal,
David S. Snyder,
Andrew Artz,
Stephen Forman
and other authors.
,
Ahmed Aribi,
Dat Ngo,
Jianying Zhang,
Karamjeet Sandhu,
Monzr Al‐Malki,
Haris Ali,
Paul Koller ,
Shukaib Arslan ,
Elizabeth Budde,
Samer Khaled,
Sanjeet Dadwal,
David S. Snyder,
Andrew Artz,
Stephen Forman
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 